Artículos del autor

solaci

Coronary disease

The Most Read Articles of August in solaci website

1-FDA Expands TAVR Indication to Low-Risk Patients Both the self-expandable valve Evolut R and its direct competitor, balloon-expandable...
solaci -
Mitral valve

MitraClip in the Real World: Mid-Term Progress

Courtesy of Dr. Carlos Fava. The fact that the outcomes of edge-to-edge repair with MitraClip have improved, particularly...
solaci -
Acute coronary syndromes

Is Complete Revascularization the Right Choice in Acute Myocardial Infarction with Multivessel Disease?

Courtesy of Dr. Carlos Fava. Primary coronary angioplasty has been the treatment of choice for acute myocardial...
solaci -
Peripheral vascular disease

Should We Start Using the Retrograte Access in Critical Limb Ischemia?

Courtesy of Dr. Carlos Fava. Peripheral vascular disease in lower limbs is on the rise. Antegrade recanalization is...
solaci -
Institutional News

To the Beat of SOLACI-CACI 2020: An Interview with Dr. Aníbal Damonte

After yet another successful SOLACI Congress, we are renewing our energy by preparing for our next event,...
solaci -
Aorta

The Real Impact of Peripheral Artery Disease in TAVR

Courtesy of Dr. Carlos Fava. The real incidence of peripheral artery (PAD) disease in TAVR remains unclear. Different...
solaci -
Structural heart disease

ESC 2019 | How Benign Is Moderate Aortic Stenosis?

Data from a great Australian registry of nearly 250,000 people with a 5-year follow-up, presented at the...
solaci -
Coronary disease

Theoretical Advantages Translated into Worst Clinical Outcomes: Synergy vs. Xience

New data from a real-world registry soon to be published in J Am Coll Cardiol Intv suggest...
solaci -